Kalani
Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
About Kalani
Kalani is recorded as Analyst at Goldman Sachs. Kalani has spoken on 1 earnings call across 1 company, most recently for Arcutis Biotherapeutics, Inc. on August 5, 2026. The companies whose calls Kalani spoke on are classified in the Healthcare sector.
Kalani on recent calls
“The first one on the commercial front, as you guys think about launching the PCP and the pediatric sales team for Zareve in the coming months, how many patients do you believe are not adequately referred to dermatologists from the PCPs and pediatricians?”
Affiliation history
-
Goldman Sachs
Analyst
Transcript header (unverified)
Current